ArticleJournal of natural products2026
Curation of Mass Spectrometry Reference Data for Improved Identification and Dereplication of Cyanobacterial Specialized Metabolites.
Article in Journal of natural products, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-resolution tandem mass spectrometry (HRMS/MS) is a powerful tool for screening organic compounds in complex samples. A critical step in identifying candidate structures is the comparison of sample HRMS/MS spectra with those of reference spectral libraries. The effectiveness of this spectral matching hinges on two key factors: (i) how well the library's content aligns with the suspect compound list and (ii) the quality and diversity of the reference spectra for each compound. Yet the scarcity of natural product reference materials on the market often necessitates non-targeted analysis. In this study, we systematically acquired and curated HRMS/MS reference spectra for specialized metabolites from cyanobacteria, which are vastly underrepresented in the current libraries. Previously, MassBank EU included spectra for only 14 such compounds. We have significantly expanded the publicly available data, contributing 2905 unique spectra representing 150 distinct cyanobacterial metabolites. A proof-of-concept analysis demonstrates up to 5-fold increased annotation success and revealed shortcomings in current libraries, underscoring the need for continued data enrichment. In particular, future efforts should prioritize the inclusion of HRMS/MS spectra for diverse adduct ions to improve identification confidence and broaden the analytical coverage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.